5 Stocks to Buy Trading Under $10 That Are Household Names
These five well-known blue-chip companies are likely to survive the current troubles and could very well offer patient investors some huge returns over the next year or so.
These five well-known blue-chip companies are likely to survive the current troubles and could very well offer patient investors some huge returns over the next year or so.
Investors holding these shares, or aggressive accounts looking for new short ideas, should consider taking a long look at these troubled stocks.
These five top large-cap leaders hit all the metrics for inclusion in the BofA Securities Yield Advantage club of income-generating stocks most likely to outperform.
These four top capital markets stocks offer solid upside to the Goldman Sachs target prices, and with all four paying out dividends, the total return potential is also a solid positive.
The energy sector will remain volatile, but scale buying shares now and being patient could bring some very solid gains for investors over the rest of 2020.
These five stocks could be big winners if the recovery is W-shaped and we and we return to the March lows before turning higher. They also have had substantial insider buying recently, a good…
These five stocks could be big winners if the recovery is U-shaped and we trade sideways for a while before turning higher. They also have had substantial insider buying recently, a good sign for…
These five stocks could be big winners if the recovery is V-shaped and sooner rather than later. They also have had strong insider buying during the recent downturn and comeback rally, a good sign…
Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies is a proverbial one-trick pony, and they all are potential takeover candidates.
The analysts at BofA Securities have made a big move by removing a high-profile company from the firm's well-respected US 1 list of stocks to buy. Some other picks look especially intriguing now.
These five energy stocks rated Buy at BofA Securities and trading below the $10 level could be huge winners for patient investors who can see beyond the current turmoil.
Proper asset allocation should always include a holding of precious metals. Not only does it have the potential to hedge inflation over the long term, but such a position can really help if the…
These four semiconductor stocks are rated Buy at Merrill, come with big dividends and make sense for both income fund managers and more aggressive retail investors.
For cautious investors looking to avoid FANG stocks and the like, here are five that make sense now. They are reasonably conservative, pay good and reliable dividends, and also have good upside potential.
These four top companies are raising dividends into one of the most unpredictable and volatile markets we have seen in years. For investors looking for ideas, these are all incredible companies that should be…
While working from home is not for everybody, it is something that will only grow in the years to come. Those companies that embrace it after the pandemic subsides will see numerous benefits, as…
These three leaders in the digital advertising world make sense for aggressive growth accounts looking to add shares of companies that are dominant in a space that will continue to grow in the years…
These five top biotech companies range from a large-cap leader with a potential coronavirus treatment to a small-cap company with massive upside potential.
These five well-known, blue-chip companies that are likely to survive the current troubles and could very well offer patient investors some huge returns over the next year or so.
These five stocks are trading under $10 per share and could be massive bargains now and have big upside to the price targets. They are not penny stocks with absolutely no track record or…